Suppr超能文献

PU.1 和 Spi-B 缺失诱导的 B 细胞白血病小鼠模型中的 Janus 激酶驱动突变。

Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B.

机构信息

Department of Microbiology & Immunology and.

Centre for Human Immunology, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.

出版信息

Blood Adv. 2018 Nov 13;2(21):2798-2810. doi: 10.1182/bloodadvances.2018019950.

Abstract

Precursor B-cell acute lymphoblastic leukemia (B-ALL) is associated with recurrent mutations that occur in cancer-initiating cells. There is a need to understand how driver mutations influence clonal evolution of leukemia. The E26-transformation-specific (ETS) transcription factors PU.1 and Spi-B (encoded by and ) execute a critical role in B-cell development and serve as complementary tumor suppressors. Here, we used a mouse model to conditionally delete and genes in developing B cells. These mice developed B-ALL with a median time to euthanasia of 18 weeks. We performed RNA and whole-exome sequencing (WES) on leukemias isolated from Mb1-CreΔPB mice and identified single nucleotide variants (SNVs) in , , and genes, resulting in amino acid sequence changes. mutations resulted in amino acid substitutions located in the pseudo-kinase (R653H, V670A) and in the kinase (T844M) domains. Introduction of T844M into /-deficient precursor B cells was sufficient to promote proliferation in response to low IL-7 concentrations in culture, and to promote proliferation and leukemia-like disease in transplanted mice. We conclude that mutations in Janus kinases represent secondary drivers of leukemogenesis that cooperate with / deletion. This mouse model represents a useful tool to study clonal evolution in B-ALL.

摘要

前 B 细胞急性淋巴细胞白血病 (B-ALL) 与癌症起始细胞中发生的复发性突变有关。需要了解驱动突变如何影响白血病的克隆进化。E26 转化特异性 (ETS) 转录因子 PU.1 和 Spi-B(由 和 编码)在 B 细胞发育中发挥关键作用,并作为互补的肿瘤抑制因子。在这里,我们使用一种小鼠模型在发育中的 B 细胞中条件性删除 和 基因。这些小鼠在 18 周时因安乐死而发展为 B-ALL。我们对 Mb1-CreΔPB 小鼠分离的白血病进行了 RNA 和全外显子测序 (WES),并在 、 、 和 基因中鉴定出单核苷酸变异 (SNV),导致氨基酸序列改变。 突变导致氨基酸取代位于假激酶 (R653H、V670A) 和激酶 (T844M) 结构域。将 T844M 引入 /-缺陷前 B 细胞足以促进在低浓度 IL-7 培养物中的增殖,并促进移植小鼠中的增殖和白血病样疾病。我们得出结论,Janus 激酶突变代表了白血病发生的次要驱动因素,与 / 缺失协同作用。这种小鼠模型代表了研究 B-ALL 中克隆进化的有用工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验